← FDA Drug Approvals (Drugs@FDA)
LISDEXAMFETAMINE DIMESYLATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALKEM LABS LTD · Approved 2023-08-25
Drug application
- FDA Application #
ANDA217194- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LISDEXAMFETAMINE DIMESYLATE
- Generic name
- Lisdexamfetamine Dimesylate
- Active ingredients
- LISDEXAMFETAMINE DIMESYLATE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ALKEM LABS LTD
- First approval
- 2023-08-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown